Colt CZ Group (CZG) Q4 2025 earnings summary

Executive summary

• Achieved growth across all financial metrics in 2025, with improved overall margin and stable profitability despite US market softness.

• Net profit surged by 95.7% year-over-year to CZK 2.04 billion in 2025, driven by strong ammunition segment growth and full-year consolidation of Sellier & Bellot.

• Ammunition segment in Europe and integration of Synthesia Nitrocellulose (NCL) drove performance.

• Strategic investments and acquisitions enhanced vertical integration and supply chain resilience, positioning for long-term growth.

• Strategic acquisition of NCL finalized in January 2026, expanding into the energetics market.

Financial highlights

• Revenues reached CZK 23,398 million, up 4.6% year-over-year.

• Adjusted EBITDA was CZK 4,661 million, up 1.4% year-over-year; reported EBITDA (including extraordinary items) rose 38.2% to CZK 4.8 billion.

• Adjusted Net Profit rose 5% to CZK 2,030 million; reported net profit was CZK 2.04 billion.

• Adjusted EPS was CZK 36.0, impacted by an 18.5% increase in average share count.

• Capital expenditures increased 12.3% year-over-year to CZK 1.04 billion, representing 4.4% of total revenues.

Outlook and guidance

• 2026 guidance: revenues CZK 30–33 billion, adjusted EBITDA CZK 7.4–8.2 billion, adjusted EPS CZK 50 (before PPA amortization).

• Energetics segment anticipated to contribute 16% of revenues and 32% of adjusted EBITDA in 2026.

• Growth expected from new energetics segment, government contracts, and Colt Optics division launch.

• Management targets EBITDA exceeding upper end of guidance.

• Focus on mitigating U.S. market slowdown, cost control, and new product launches.